Clinical Trial Details


Research Study Summary

Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.


A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of xxxxxxxxx in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)

Patient Inclusion Criteria:

  • Subjects must be willing and able to give signed and dated written informed consent.
  • Subjects must have type 2 diabetes with inadequate glycemic control obtained at the enrollment visit.
  • Subjects must have inadequately controlled hypertension
  • Men and women ages must be ≥ 18 and ≤ 89 years old at the time of the enrollment visit. Men and women of childbearing potential (WOCBP) must be using an acceptable method of contraception to avoid pregnancy throughout the study in such a manner that the risk of pregnancy is minimized.
  • Women must not be breastfeeding

Patient Exclusion Criteria:

  • History of diabetes insipidus.
  • History of malignant or accelerated hypertension.
  • Subject is currently abusing alcohol or other drugs or has done so within the last 6 months.

Additional protocol-defined inclusion/exclusion criteria may apply, please contact us for more information.

To Learn more

CW ID: 182530
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Both Male and Female
18 to 89 Years
Overall Status
Facility Type


Luis Estevez, Clinical Research Coordinator
IMA Research
1431 NW 13th Terr
Miami, FL 33125
Phone: 866-879-2507 Ext 705

View Map

Research Center Information:

IMA Research

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.